Michael Zezas: The U.S. Election, Clean Energy and Healthcare

Michael Zezas: The U.S. Election, Clean Energy and Healthcare

Investors are concerned about the potential impact of the upcoming U.S. presidential election in a number of sectors. Here’s what to watch.


----- Transcript -----

Welcome to the Thoughts on the Market. I'm Michael Zezas, Global Head of Fixed Income and Thematic Research from Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about the impact of the U.S. elections on markets. It's Wednesday, December 13th at 10 a.m. in New York.


Following our publication last week of our early look for investors at the U.S. election, we've had plenty of discussion with clients trying to sort out what the event might mean for markets. Here's the three most frequently asked questions we've received and of course, our answers.


First, could the election be a catalyst to undo planned investment into the clean energy industry? This question often gets asked as, under what conditions could the Inflation Reduction Act be repealed? That Act allocated substantial sums to investment in clean energy alternatives, a boon for the industry. In our view, we don't see that act being repealed, even if Republicans who oppose the act take control of both Congress and the White House. We think there's too many negative local economic consequences to undoing that investment, to get a sufficient number of Republicans to vote for the repeal. However, clean energy investors should note that a Republican administration might be able to slow the spend of that money using the regulatory process.


Second, should healthcare investors be concerned that there's an election outcome that could substantially change the U.S. healthcare system? This was a concern in prior elections where Republicans promised to repeal the Affordable Care Act, an outcome current President Trump has recommitted to in his current campaign. Republicans couldn't make good on that promise, despite unified government control in 2017 and 2018. And here we think history would repeat itself with even a Republican majority having difficulty finding sufficient votes if it means restricting health care delivery to some of their voters. That said, investors in sectors that would be negatively impacted by a repeal of the Affordable Care Act could see market effects if Republicans start surging in the polls, as markets would then have to account for the possibility, albeit modest, of repeal.


Finally, when might political campaigns begin impacting markets? We don't have a clear answer here. In 2016 and 2020, health care stocks started reflecting campaign statements early in the year. Whereas macro market effects, such as the sensitivity of the Mexican peso to then candidate Trump's comments around renegotiating trade agreements, didn't kick in until much closer to November. The bottom line is that we don't really know, which is why we're here to help you prepare now.


Thanks for listening. If you enjoy the show, please share Thoughts on the Market with a friend or colleague, or leave us a review on Apple Podcasts. It helps more people find the show.

Episoder(1515)

Andrew Sheets: Rates and Inflation - Moving for the Right Reasons?

Andrew Sheets: Rates and Inflation - Moving for the Right Reasons?

Rising yields and inflation can create anxiety for investors, but the impact depends on why they’re rising. Chief Cross-Asset Strategist Andrew Sheets explains.

14 Jan 20212min

Adam Virgadamo: 5 Equities Investment Themes for 2021

Adam Virgadamo: 5 Equities Investment Themes for 2021

As vaccines continue to roll out and the world eyes a return to normal, several key themes are emerging that could shape investment returns.

13 Jan 20213min

Reza Moghadam: High Noon at the ECB Corral

Reza Moghadam: High Noon at the ECB Corral

Does a robust recovery in 2021 spell the end of European Central Bank action? One inconvenient fact may stand in the way: the lackluster rise in inflation.

12 Jan 20214min

Mike Wilson: So… What Isn’t Priced-In?

Mike Wilson: So… What Isn’t Priced-In?

Although 2021 is likely to be a better year economically, asset markets may not repeat the remarkable run of the past 9 months. So where should investors look?

11 Jan 20214min

Special Episode: Are the Clouds Clearing for European Equities?

Special Episode: Are the Clouds Clearing for European Equities?

Why a reflationary backdrop in 2021 could provide a boost to Europe’s cyclical value stocks. A look at the year ahead with Graham Secker, Head of the European and UK Equity Strategy Team.

8 Jan 202110min

Andrew Sheets: Three Implications of the “Blue Wave”

Andrew Sheets: Three Implications of the “Blue Wave”

Chief Cross-Asset Strategist Andrew Sheets explains why a Democrat sweep of Congress and the White House suggests more reflation and rotation in portfolios.

7 Jan 20213min

Michael Zezas: Georgia Changes the Game

Michael Zezas: Georgia Changes the Game

With wins called for both Senate runoff elections in Georgia, Democrats are poised to control the Presidency and both chambers of Congress. What does this mean for further stimulus?

7 Jan 20212min

Reza Moghadam: New Year, New Europe

Reza Moghadam: New Year, New Europe

With Brexit finally a reality, Chief Economic Advisor Reza Moghadam details key elements of the agreement—and the resulting market implications for the EU and UK.

5 Jan 20215min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
lydartikler-fra-aftenposten
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
finansredaksjonen
rss-vass-knepp-show
livet-pa-veien-med-jan-erik-larssen
pengepodden-2
tid-er-penger-en-podcast-med-peter-warren
morgenkaffen-med-finansavisen
okonomiamatorene
utbytte
rss-markedspuls-2
lederpodden
rss-sunn-okonomi
rss-fri-kontantstrom
rss-impressions-2
aksjepodden